Syringoma is a benign neoplasm arising from the sebaceous or sweat glands, characterized by the formation of small, dense nodules on the skin, mainly in the area of the eyelids, cheeks, forehead and upper chest. This disease is most often observed in women aged 20-50 years and can have both sporadic and hereditary manifestations. The main mechanism of syringoma formation is associated with a violation of the development and maturation of sweat glands, which leads to the formation of abnormal structures, including small cysts. Despite the fact that syringoma is not a dangerous disease, its cosmetic manifestations can cause significant discomfort in patients and negatively affect their quality of life.
History of the disease and interesting historical facts
Syringoma was first described in medical literature in the late 19th century. One of the first physicians to study this condition was the German dermatologist A. E. Charlotte, who in 1872 published observations of lesions of the sweat glands with a characteristic clinical picture and morphology. Over time, modern histological methods made it possible to study the pathogenesis of the disease in more detail. In the 20th century, syringoma began to be actively studied due to the growing interest in dermatological diseases and improved diagnostic methods. Studies conducted in the 1970s and 1980s confirmed a significant number of cases of syringoma, especially among women, making it one of the most studied dermatological problems.
Epidemiology
Syringoma is reported to occur in 2-3% of the population, with a significant predisposition among women, especially those aged 20 to 50 years. According to some sources, the incidence of syringoma may reach up to 10% in certain populations. The incidence data varies depending on different ethnic groups and geographic regions. For example, studies conducted in Asian countries have shown a higher predisposition to syringoma compared to European and African populations. There is also evidence of a possible association of syringoma with other dermatological conditions, such as actinic keratosis and melanocytic nevi.
Genetic predisposition to this disease
Some studies suggest a genetic predisposition to syringoma, particularly among patients with a family history of the disease. The genes involved in syringoma pathogenesis remain unclear, but mutations have been identified in some genes encoding proteins involved in sweat gland function. For example, the keratin-associated KRT17 gene is thought to play a role in epithelial cell formation and function, which may be associated with syringoma formation.
Risk factors for the development of this disease
Among the risk factors for the development of syringoma are the following:
- Age: the disease is more common in young and middle-aged women;
- Gender: a marked predisposition in women compared to men;
- Ethnicity: increased risk in some ethnic groups;
- There is an association with a number of dermatological conditions such as pyoderma and atopic dermatitis;
- Environmental factors, including elevated levels of ultraviolet radiation.
Diagnosis of this disease
The main symptoms of syringoma include the appearance of small, dense nodules on the skin, which may be flesh-colored or yellowish. These nodules are most often located in the eyelids, forehead, or neck. A number of methods are used to diagnose syringoma:
- Clinical examination: doctors pay attention to characteristic lesions, their color and location;
- Laboratory tests: Skin biopsy provides the opportunity for histological examinations that confirm the diagnosis;
- Radiological examinations: in rare cases, they are carried out when it is necessary to exclude other neoplasms;
- Differential diagnosis: Syringoma should be distinguished from other skin diseases such as milia and keratoses.
Treatment
Treatment of syringoma can be both cosmetic and surgical.
General treatment may include:
- Cosmetic procedures: use of lasers and chemical peels;
- Pharmacological treatment: use of creams containing vitamin A and other regenerating substances;
- Surgical treatment: removal of nodules using cryodestruction or electrodesiccation;
- Other treatments include corticosteroid injections to reduce inflammation and skin hyperplasia.
List of medications used to treat this disease
The most commonly used drugs for the treatment of syringoma are:
- Topical retinoids (tretinoin);
- Corticosteroids for injection;
- Laser means (eg carbon dioxide laser);
- Cryogenic agents for cryodestruction;
- Chemical peels.
Disease monitoring
Syringoma monitoring includes regular check-ups with a dermatologist to monitor the progression of the disease and possible recurrence after treatment. The prognosis for patients with syringoma is usually favorable, but in rare cases complications such as inflammation or infection after surgery may occur.
Age-related features of the disease
Syringoma can occur in different age groups, but is most often diagnosed in young adults and middle-aged people. Syringoma is extremely rare in children and usually requires special attention during diagnosis, as it can be associated with other skin diseases.
Questions and Answers
- What are the main symptoms of syringoma? The main symptoms of syringoma include the appearance of small, firm nodules on the skin, which may be flesh-colored or yellowish in color and are most often located in the eyelids, forehead, or neck.
- Who is more susceptible to the disease? Syringoma is more common in women, especially those between the ages of 20 and 50, and may be associated with a family history.
- What is the treatment for syringoma? Treatment may include cosmetic procedures, surgery, and medications such as retinoids and corticosteroids.
- Can syringoma development be prevented? There are no specific measures to prevent the development of syringoma, but regular examinations by a dermatologist can help in early detection and treatment.
- What is the likelihood of relapse after treatment? Recurrences of syringoma may occur, but the likelihood of their occurrence depends on the individual characteristics of the patient and the treatment methods used.
